Formulation Development Outsourcing Market Key Players Analysis - Charles Rover Laboratories (US), Laboratory Corporation of America (US), Intertek (US), Recipharm.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Formulation Development Outsourcing Market Size, Share & Trends Analysis Report By Service (Preformulation, Formulation Development), Application (Oncology, Neurology, Infectious Disease, Respiratory, Dermatology) And Formulation (Injectable, Topical, Inhaled, Oral) Market Outlook And Industry Analysis 2031"

The formulation development outsourcing market is estimated to reach 69.54 billion by the year 2031 , exhibiting a CAGR of 7.80% during the forecast period.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1848

Fluctuations in the pricing and demand for various medicines and raw materials can have a significant impact on the outsourcing of formulation development. Companies specializing in formulation development outsourcing have leveraged the expiration of medical drug patents as a strategic marketing tool to foster market growth. Over the past few years, the demand for development services, particularly those related to formulation and bioavailability, has seen substantial growth. Pharmaceutical companies are key players in this market, focusing on the development and production of new formulations and medications.

These stakeholders collaborate to deliver efficient drugs and gene therapies that support the biotechnology sector. Moreover, the integration of innovative techniques and pharmaceutical services by major market players is expected to drive further market expansion throughout the forecast period. To remain competitive, formulation development outsourcing companies are increasingly focused on developing and launching a wide range of products to meet rising customer demand and enhance revenue generation.

List of Key Players in the Formulation Development Outsourcing Market:
• SGS S.A.
• Intertek Group plc
• Recipharm
• Lonza
• Charles River Laboratories International, Inc.
• Eurofins Scientific SE
• Element
• Labcorp
• Thermo Fisher Scientific, Inc. (Patheon)
• Catalent Inc.

Market Dynamics:
Drivers-
The formulation development outsourcing market is experiencing steady growth and is projected to achieve a robust compound annual growth rate (CAGR) during the forecast period. The increasing demand for formulation development outsourcing across various end-use industries, including oncology, infectious diseases, and respiratory care, is a key driver of market expansion. The pharmaceutical sector is expected to dominate the market, capturing a significant share throughout the forecast period. Additionally, the growth of research centers and the biopharmaceutical sector are contributing to the overall development of the market. These factors collectively play a crucial role in driving the global growth of formulation development outsourcing.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

Challenges:
A significant challenge facing the formulation development outsourcing market is the high initial investment required, coupled with limited awareness of the formulation sector in developing economies. These factors are expected to hinder market growth. Furthermore, the COVID-19 pandemic disrupted the operations of major pharmaceutical companies, affecting production capabilities, supply chains, and the export of critical medications. Lockdown measures, particularly those implemented by the Chinese government, led to shortages of essential raw materials. As a response, several countries have initiated strategies to promote domestic active pharmaceutical ingredient (API) manufacturing. In addition, various European Union nations have re-evaluated their healthcare systems to enhance resilience against future pandemics and ensure consistent API availability.

Regional Trends:
North America is expected to generate the highest revenue in the coming years, driven by the rising prevalence of chronic diseases and the strong presence of leading market players, particularly in the United States. With many prominent pharmaceutical products nearing the end of their patent protection, key industry participants are increasingly investing in novel drug formulation development through outsourcing, which is anticipated to fuel regional market growth. In Europe, the United Kingdom held the largest share of the formulation development outsourcing market, while Germany emerged as the fastest-growing market within the region.

Recent Development:
• In 2021, Catalent announced it had engaged in a definitive agreement to acquire Acorda Therapeutics, Inc.'s manufacturing and packaging operations. The acquisition bolsters Catalent's position as a leading U.S. partner for dry powder inhaled dosage form manufacturers. Catalent has also signed a long-term supply agreement with Acorda Therapeutics to continue commercial production of INBRIJA® (levodopa inhalation powder) at its Chelsea facility.
• In 2021, Quotient Bioscience also disclosed plans to acquire Arcinova, a United Kingdom-based business. With the acquisition, Quotient Bioscience can offer more services, such as medical goods, clinical testing, and drug substance development.
• In 2020, Catalent, Inc. announced the completion of its acquisition of MaSTherCell Global, Inc., establishing Catalent as a leading technology, development, and manufacturing partner for innovators of advanced biotherapeutics. Catalent is well-positioned to lead the industry with its cell & gene therapy platforms after acquiring MaSTherCell's novel portfolio of autologous and allogeneic cell therapy-related capabilities, technologies, and analytical services.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1848

Segmentation of Formulation Development Outsourcing Market:
Service Outlook
• Preformulation
• Formulation Development
By Formulation -
• Injectable
• Oral
• Topical
• Inhaled
• Others
By Application -
• Oncology
• Genetic Disorders
• Neurology
• Infectious Disease
• Respiratory
• Cardiovascular
• Other application
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/formulation-development-outsourcing-market-/1848

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.